Patents 311show all

  • 158
    A61K - Preparations for medical, dental, or toilet purposes
  • 153
    C07D - Heterocyclic compounds
  • 21
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 9
    C07C - Acyclic or carbocyclic compounds
  • 3
    A61B - Diagnosis
  • 2
    B82Y - Specific uses or applications of nanostructures
  • 2
    C08B - Polysaccharides
  • 2
    C08L - Compositions of macromolecular compounds

Clinical Trials 13show all

5Phase 24Phase 33Phase 11N/A

SEC Filings show all


63
8-K

18
10-Q

7
D

6
10-K

1
S-1

Contact Information

Boston, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2012-12-05Indefinite$21,761,570Equity
2012-08-28Indefinite$3,000,000Debt
2011-07-12Indefinite$6,085,933Equity
2010-03-02$10,125,000$8,100,000Equity
2008-11-03Unknown Unknown Other (Paper Filing)

Key Executives

  • Thomas Hughes
    Executive Officer, Director
  • Matthias Jaffe
    Executive Officer
  • Mitchell S. Bloom
    Executive Officer
  • Peter Barrett
    Director
  • Avi Goldberg
    Director
  • Kevin Starr
    Director
  • Bruce Booth
    Director
  • Dr. Liam Ratcliffe
    Director
  • Louis Tartaglia
    Director
  • Frances Heller
    Director
  • Lou Tartaglia
    Director
  • Mitchell Bloom
    Executive Officer
  • Dennis D. Kim
    Executive Officer